Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test may predict COVID-19 ICU outcomes

NCT ID NCT07244731

First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 12 times

Summary

This study looked at whether a common blood test measure called RDW (red blood cell distribution width) can help predict how severe COVID-19 patients will do in the intensive care unit. Researchers followed 146 adults with severe or critical COVID-19 in the ICU and checked if higher RDW levels were linked to needing a breathing tube or dying. The goal was to see if RDW could be a useful early warning sign for doctors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ankara University

    Ankara, Ankara, 06340, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.